Literature DB >> 21898069

Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea.

Joong Kyong Ahn1, Ji-Won Hwang, Jaejoon Lee, Chan Hong Jeon, Hoon-Suk Cha, Eun-Mi Koh.   

Abstract

The classification system for antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis and polyarteritis nodosa had its limitations due to numerous overlapping features of these disease entities. The aim of this study is to investigate the clinical features and outcome of patients diagnosed with microscopic polyangiitis (MPA) according to the newly proposed consensus algorithm of ANCA-associated vasculitides and polyarteritis nodosa. Fifty-five cases of MPA, comprised of 33 men and 22 women, diagnosed according to a new consensus algorithm at a single tertiary hospital were identified for analysis. The main clinical features were constitutional symptoms (78.2%), followed by renal involvement (74.5%), musculoskeletal symptoms (67.3%), skin manifestations (50.9%), neurologic involvement (43.6%), and lung involvement (41.8%). P-ANCA and/or anti-myeloperoxidase antibody were present in 69.1%. Five Factor Score and Birmingham Vasculitis Activity Score (BVAS) at diagnosis were 1.1 ± 0.9 and 10.9 ± 4.9, respectively. Forty-four patients were available for a long-term follow-up, and six patients (13.6%) resulted in death. Mortality was associated with BVAS > 9 at the time of diagnosis, age > 60 years, and presence of cardiomyopathy and interstitial lung disease. The survival rate at 1 and 3 years was 93.9 and 89.2%, respectively. Eight patients (14.5%) required dialysis at the time of diagnosis. This is the first study to demonstrate the clinical features in patients with MPA using a new consensus algorithm. Survival rate was higher than previously reported, and interstitial lung disease was a new risk factor for death in patients with MPA.

Entities:  

Mesh:

Year:  2011        PMID: 21898069     DOI: 10.1007/s00296-011-2079-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  29 in total

1.  Epidemiology of vasculitis in Europe.

Authors:  R A Watts; S E Lane; D G Scott; W Koldingsnes; H Nossent; M A Gonzalez-Gay; C Garcia-Porrua; G A Bentham
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

2.  Microscopic polyangiitis presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?

Authors:  Julius Birnbaum; Sonye Danoff; Frederic B Askin; John H Stone
Journal:  Arthritis Rheum       Date:  2007-06

3.  Primary systemic vasculitis: clinical features and mortality.

Authors:  S E Lane; R A Watts; L Shepstone; D G I Scott
Journal:  QJM       Date:  2005-01-17

4.  Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.

Authors:  Omran Bakoush; Mårten Segelmark; Ole Torffvit; Sophie Ohlsson; Jan Tencer
Journal:  Nephrol Dial Transplant       Date:  2006-01-31       Impact factor: 5.992

5.  Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions.

Authors:  V D'Agati; P Chander; M Nash; R Mancilla-Jimenez
Journal:  Am J Kidney Dis       Date:  1986-01       Impact factor: 8.860

6.  Vasculitis affecting the kidney: presentation, histopathology and long-term outcome.

Authors:  A Serra; J S Cameron; D R Turner; B Hartley; C S Ogg; G H Neild; D G Williams; D Taube; C B Brown; J A Hicks
Journal:  Q J Med       Date:  1984

7.  Malignancy is increased in ANCA-associated vasculitis.

Authors:  T Pankhurst; C O S Savage; C Gordon; L Harper
Journal:  Rheumatology (Oxford)       Date:  2004-08-17       Impact factor: 7.580

8.  Polyarteritis and the kidney.

Authors:  D Adu; A J Howie; D G Scott; P A Bacon; R J McGonigle; J Micheal
Journal:  Q J Med       Date:  1987-03

Review 9.  Vasculitis: a collection of pearls and myths.

Authors:  John H Stone
Journal:  Rheum Dis Clin North Am       Date:  2007-11       Impact factor: 2.670

10.  Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.

Authors:  Christian Pagnoux; Susan L Hogan; Hyunsook Chin; J Charles Jennette; Ronald J Falk; Loïc Guillevin; Patrick H Nachman
Journal:  Arthritis Rheum       Date:  2008-09
View more
  10 in total

1.  Clinical role of albumin to globulin ratio in microscopic polyangiitis: a retrospective monocentric study.

Authors:  Sung Soo Ahn; Juyoung Yoo; Seung Min Jung; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Clin Rheumatol       Date:  2018-09-15       Impact factor: 2.980

Review 2.  ANCA-Associated Vasculitis Pathogenesis: A Commentary.

Authors:  Eric J Gapud; Philip Seo; Brendan Antiochos
Journal:  Curr Rheumatol Rep       Date:  2017-04       Impact factor: 4.592

Review 3.  ANCA-associated vasculitis: report from Korea.

Authors:  Hye Won Kim; Yeong Wook Song
Journal:  Clin Exp Nephrol       Date:  2013-01-05       Impact factor: 2.801

4.  Interstitial lung disease and microscopic polyangiitis in chilean patients.

Authors:  Pamela Wurmann; Francisca Sabugo; Fabian Elgueta; Macarena Mac-Namara; Karen Vergara; Daniela Vargas; Maria Luisa Molina; Juan Carlos Díaz; Hector Gatica; Annelise Goecke
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-15       Impact factor: 0.670

5.  Retrospective analysis of factors predicting end-stage renal failure or death in patients with microscopic polyangiitis with mainly renal involvement.

Authors:  Hirohisa Kawai; Shogo Banno; Shogo Kikuchi; Nahoko Nishimura; Hironobu Nobata; Yukihiro Kimura; Yumiko Takezawa; Mari Ogawa; Keisuke Suzuki; Wataru Kitagawa; Naoto Miura; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2013-12-21       Impact factor: 2.801

6.  Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome.

Authors:  Godasi S R S N K Naidu; Aman Sharma; Ritambra Nada; Harbir Singh Kohli; Vivekanand Jha; Krishan Lal Gupta; Vinay Sakhuja; Manish Rathi
Journal:  Rheumatol Int       Date:  2014-05-18       Impact factor: 2.631

7.  Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.

Authors:  Ken-ei Sada; Masahiro Yamamura; Masayoshi Harigai; Takao Fujii; Hiroaki Dobashi; Yoshinari Takasaki; Satoshi Ito; Hidehiro Yamada; Takashi Wada; Junichi Hirahashi; Yoshihiro Arimura; Hirofumi Makino
Journal:  Arthritis Res Ther       Date:  2014-04-23       Impact factor: 5.156

8.  Simple, readily available clinical indices predict early and late mortality among patients with ANCA-associated vasculitis.

Authors:  Ágnes Haris; Kálmán Polner; József Arányi; Henrik Braunitzer; Ilona Kaszás; László Rosivall; Gábor Kökény; István Mucsi
Journal:  BMC Nephrol       Date:  2017-02-23       Impact factor: 2.388

9.  Commentary: Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.

Authors:  Samuel Wacrenier; Charlotte Boud'hors; Giorgina Piccoli; Jean-François Augusto; Benoit Brilland
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

10.  Clinical characteristics and outcomes in microscopic polyangiitis patients with renal involvement: a study of 124 Chinese patients.

Authors:  Jia Shi; Qing Shen; Xue-Mei Chen; Xiao-Gang Du
Journal:  BMC Nephrol       Date:  2019-09-02       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.